Thomas Hamilton
Net worth: 5 M $ as of 31/05/2026
Net worth: 5 M $ as of 31/05/2026
Founder of CureFA Foundation, Thomas Edward Hamilton presently occupies the position of Chairman at Chondrial Therapeutics, Inc., Chairman at Chondrial Therapeutics Holdings LLC and President & Chief Executive Officer for Construction Forms, Inc. Mr. Hamilton is also on the board of Annaly Capital Management, Inc. (former Chairman), The Friedreich's Ataxia Research Alliance and Larimar Therapeutics, Inc. In the past Mr. Hamilton occupied the position of Managing Director at Citigroup, Inc. and Managing Director at Salomon Brothers, Inc. (a subsidiary of Citigroup, Inc.) and Head of Securitized Products Trading at Barclays Capital, Inc.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/05/2026 | 824,231 ( 0.96% ) | 3 M $ | 31/05/2026 | |
| 10/06/2026 | 115,000 ( 0.02% ) | 3 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Director/Board Member | 28/05/2020 |
| ANNALY CAPITAL MANAGEMENT, INC. | Chairman | 06/03/2019 |
Construction Forms, Inc.
Construction Forms, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Designs, manufactures and delivers concrete pumping & placing equipment | Director/Board Member | 01/01/2013 |
The Friedreich's Ataxia Research Alliance
The Friedreich's Ataxia Research Alliance Information Technology ServicesTechnology Services Provides patient registry services | Director/Board Member | - |
Chondrial Therapeutics Holdings LLC
Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Chairman | - |
| Companies | Position | End |
|---|---|---|
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops orphan drugs for mitochondrial diseases | Chairman | 01/05/2020 |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Trading-Equity | 01/05/2013 |
Salomon Brothers, Inc.
Salomon Brothers, Inc. Investment Banks/BrokersFinance Investment banking services | Corporate Officer/Principal | - |
| CITIGROUP INC. | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░░░░░░░ | ░░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Annaly Capital Management, Inc.
Annaly Capital Management, Inc. Real Estate Investment TrustsFinance Operates as real estate investment trust which invests in residential mortgage-backed securities | Finance |
Citigroup, Inc.
Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops orphan drugs for mitochondrial diseases | Health Technology |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Construction Forms, Inc.
Construction Forms, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Designs, manufactures and delivers concrete pumping & placing equipment | Producer Manufacturing |
University of Dayton
University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Salomon Brothers, Inc.
Salomon Brothers, Inc. Investment Banks/BrokersFinance Investment banking services | Finance |
The Friedreich's Ataxia Research Alliance
The Friedreich's Ataxia Research Alliance Information Technology ServicesTechnology Services Provides patient registry services | Technology Services |
Chondrial Therapeutics Holdings LLC
Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
CureFA Foundation | |
Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions